Skip to main content
. 2019 Jul 3;8(3):41. doi: 10.3390/antib8030041

Figure 2.

Figure 2

Key milestones in the history of T-cell redirected bispecific antibodies (TRBAs; top) and chimeric antigen receptor (CAR)-T cell (bottom) therapeutics. Specific references cited for TRBAs are: Milstein and Cuello, 1983 [38], Staerz et al., 1985 [41], Clark and Waldmann, 1987 [48], Nitta et al., 1990 [49], Haagen et al., 1992 [50], De Gast et al., 1995 [51], Mack et al., 1995 [45], Ridgeway et al., 1996 [52], Zeidler et al., 1999 [53] and Löffler et al., 2000 [54]. Specific references for CAR-T development cited are: Rosenberg et al., 1988 [55], Gross et al., 1989 [35], Eshhar et al., 1993 [37], Hwu et al., 1993 [56] and Moritz et al., 1994 [57].